Quarterly report pursuant to Section 13 or 15(d)

Revisions of Previously Issued Financial Statements (Tables)

v3.21.1
Revisions of Previously Issued Financial Statements (Tables)
3 Months Ended
Mar. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Schedule of financial statements

 

 

Year Ended June 30, 2019

 

 

 

As reported

 

Adjustment

 

As revised

  

Consolidated Statements of Operations 

 

 

 

 

 

 

  

Change in fair value of derivative liability

 

$

$

(2,015,812

)

$

(2,015,812

)

Net loss

 

 

(12,403,215

)

 

(2,015,812

)  

 

(14,419,027

)

Net loss per share

 

 

(2.05

)

 

 

 

(2.39

)


 

 

Three Months Ended March 31, 2020

 

 

 

As reported

 

Adjustment

 

As revised

  

Condensed Consolidated Statements of Operations 

 

 

 

 

 

 

  

Change in fair value of derivative liability

 

$

$

236,917


$

236,917

Net loss

 

 

(4,744,129

)

 

236,917

 

 

(4,507,212

)

Net loss per share

 

 

(0.38

)

 

 

 

(0.36

)


 

 

Year Ended June 30, 2020

 

 

 

As reported

 

Adjustment

 

As revised

  

Consolidated Statements of Operations 

 

 

 

 

 

 

  

Change in fair value of derivative liability

 

$

$

1,962,034


$

1,962,034

Net loss attributable to Akerna shareholders

 

 

(15,534,345

)

 

1,962,034

 

 

(13,572,311

)

Net loss per share

 

 

(1.31

)

 

 

 

(1.14

)


 

 

Three Months Ended September 30, 2020

 

 

 

As reported

 

Adjustment

 

As revised

  

Condensed Consolidated Statements of Operations 

 

 

 

 

 

 

  

Change in fair value of derivative liability

 

$

$

762,646


$

762,646

Net loss attributable to Akerna shareholders

 

 

(4,741,876

)

 

762,646

 

 

(3,979,230

)

Net loss per share

 

 

(0.34

)

 

 

 

(0.28

)


 

 

Six Months Ended December 31, 2020

 

 

 

As reported

 

Adjustment

 

As revised

  

Consolidated Statements of Operations 

 

 

 

 

 

 

  

Change in fair value of derivative liability

 

$

$

746,852


$

746,852

Net loss attributable to Akerna shareholders

 

 

(16,957,334

)

 

746,852

 

 

(16,210,482

)

Net loss per share

 

 

(1.06

)

 

 

 

(1.01

)


 

 

As of June 30, 2019

 

 

 

As reported

 

Adjustment

 

As revised

  

Consolidated Balance Sheet

 

 

 

 

 

 

  

Derivative liability

 

$

$

(3,042,000

)

$

(3,042,000

)

Total liabilities

 

 

(2,442,503

)

 

(3,042,000

)  

 

(5,484,503

)

Additional paid-in capital

 

 

47,325,421


 

(1,026,188

)  

 

46,299,233


Accumulated deficit

(25,566,746 )
(2,015,812 )
(27,582,558 )

 

 

As of June 30, 2020

 

 

 

As reported

 

Adjustment

 

As revised

  

Consolidated Balance Sheet  

 

 

 

 

 

 

  

Derivative liability

 

$

$

(1,058,228

)

$

(1,058,228

)

Total liabilities

 

 

(21,955,213

)

 

(1,058,228

)  

 

(23,013,441

)

Additional paid-in capital

 

 

72,906,924


 

(1,004,450

)  

 

71,902,474


Accumulated deficit

(41,101,091 )
(53,778 )
(41,154,869 )


 

 

As of December 31, 2020

 

 

 

As reported

 

Adjustment

 

As revised

  

Consolidated Balance Sheet

 

 

 

 

 

 

  

Derivative liability

 

$

$

(311,376

)

$

(311,376

)

Total liabilities

 

 

(19,635,076

)

 

(311,376

)  

 

(19,946,452

)

Additional paid-in capital

 

 

95,090,883


 

(1,004,450

)  

 

94,086,433


Accumulated deficit

(57,872,599 )
693,074

(57,179,525 )